P596: CLINICAL IMPACT OF TP53 DISRUPTION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH A BCR INHIBITOR. A CAMPUS CLL EXPERIENCE. (23rd June 2022) - Bomben, R.; Rossi, F. M.; Vit, F.; Bittolo, T.; Zucchetto, A.; Papotti, R.; Tissino, E.; Pozzo, F.; Degan, M.; Zaina, E.; Cattarossi, I.; Nanni, P.; et al.